CellChorus is the leader in performing high‑throughput, dynamic analysis of individual cell behavior, interactions, and function over time to improve the development and delivery of cell‑based products. The company’s TIMING platform provides individual cell and sub-population data on phenotype/identity, migration, morphology, contact dynamics, survival/viability, killing/potency, biomolecule secretion, and more. These functional data enable the industry to develop and deliver new immunotherapies faster, at lower cost, at higher rates of success, and with superior manufacturing consistency. TIMING data have been featured in more than 20 publications authored by leading biopharma companies and research institutions. CellChorus has received funding from the NIH, the NSF, Y Combinator, Breakout Ventures, and founders and CEOs of life sciences companies. The TIMING platform is protected by multiple issued and pending patents.